Detalhe da pesquisa
1.
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials.
Medicina (Kaunas)
; 60(2)2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38399628
2.
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection.
Breast Cancer (Dove Med Press)
; 14: 101-111, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440873